{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:40:26Z","timestamp":1775698826532,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 048079"],"award-info":[{"award-number":["AI 048079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 072648"],"award-info":[{"award-number":["AI 072648"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 122176"],"award-info":[{"award-number":["AI 122176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS 095498"],"award-info":[{"award-number":["NS 095498"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clim.2018.07.007","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:49:15Z","timestamp":1531831755000},"page":"100-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy"],"prefix":"10.1016","volume":"194","author":[{"given":"Scott Brian","family":"Minchenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Chaparala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Oaks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Banki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andras","family":"Perl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.07.007_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0010","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J.Neurol."},{"key":"10.1016\/j.clim.2018.07.007_bb0015","article-title":"Development of myasthenia gravis in systemic lupus erythematosus","volume":"1","author":"Kigawa","year":"2014","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.clim.2018.07.007_bb0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2018.07.007_bb0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/pgmj.70.828.741","article-title":"The association of systemic lupus erythematosus and myasthenia gravis","volume":"70","author":"Vaiopoulos","year":"1994","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.clim.2018.07.007_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NDT.S8915","article-title":"Current and emerging therapies for the treatment of myasthenia gravis","volume":"7","author":"Mantegazza","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.clim.2018.07.007_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.04.005","article-title":"Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy","volume":"112","author":"Sun","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clim.2017.03.003","article-title":"CD4+ FoxP3+ T regulatory cell subsets in myasthenia gravis patients","volume":"179","author":"Kohler","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0045","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.132.4.1809","article-title":"The effect of thymectomy on lupus-prone mice","volume":"132","author":"Hang","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/ard.43.6.825","article-title":"Systemic lupus erythematosus and invasive thymoma: report of two cases","volume":"43","author":"Steven","year":"1984","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2018.07.007_bb0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/096120339700600511","article-title":"Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity","volume":"6","author":"Shoenfeld","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2018.07.007_bb0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.1780340719","article-title":"A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy","volume":"34","author":"Grinlinton","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/096120339500400108","article-title":"Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature","volume":"4","author":"Mevorach","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2018.07.007_bb0070","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0075","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0080","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","article-title":"The MG composite: a valid and reliable outcome measure for myasthenia gravis","volume":"74","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2018.07.007_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2007.04.010","article-title":"Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients","volume":"124","author":"Bonilla","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/S0049-0172(03)00133-1","article-title":"Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center","volume":"33","author":"Font","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0100","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.175.2.944","article-title":"Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and Sialoadenitis","volume":"175","author":"Bagavant","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08916939409014680","article-title":"Studies of IgG-class anticardiolipin antibodies in myasthenia gravis","volume":"18","author":"Sanmarco","year":"1994","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2018.07.007_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00000441-200601000-00004","article-title":"High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study","volume":"331","author":"Sthoeger","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clim.2018.07.007_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4+CD25highCD127low\/- T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clim.2007.10.001","article-title":"Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis","volume":"126","author":"Li","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/915864","article-title":"Immune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis","volume":"2011","author":"Halnon","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.clim.2018.07.007_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nyas.12756","article-title":"mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging","volume":"1346","author":"Perl","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2018.07.007_bb0135","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mTOR in T cells of lupus patients","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0140","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2018.07.007_bb0145","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618304492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618304492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T16:20:38Z","timestamp":1693758038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618304492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"alternative-id":["S1521661618304492"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.07.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}